These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 9350244

  • 1. [Study on the most appropriate time for Romurtide administration (Nopia) in radiotherapy patients].
    Yokouchi J, Hirabayashi S, Kanesaka N, Baba S, Amino M, Abe K.
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1967-73. PubMed ID: 9350244
    [Abstract] [Full Text] [Related]

  • 2. Restorative effect of romurtide for thrombocytopenia associated with intensive anticancer drug treatment and/or irradiation in patients with gastrointestinal cancer.
    Yano K, Matsuoka H, Seo Y, Kounoe S, Saito T, Tomoda H.
    Anticancer Res; 1995 Oct; 15(6B):2883-7. PubMed ID: 8669883
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness of thrice-weekly injection of romurutide for prophylaxis of leukocytopenia during radiation therapy].
    Kawamori J, Saito T, Maeno T, Muto H.
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1057-62. PubMed ID: 8002621
    [Abstract] [Full Text] [Related]

  • 4. Restorative activity of muroctasin on leukopenia associated with anticancer treatment.
    Tsubura E, Nomura T, Niitani H, Osamura S, Okawa T, Tanaka M, Ota K, Nishikawa H, Masaoka T, Fukuoka M.
    Arzneimittelforschung; 1988 Jul; 38(7A):1070-4. PubMed ID: 3190800
    [Abstract] [Full Text] [Related]

  • 5. [Restorative effect of muroctasin; MDP-Lys (L18) [DJ-7041] on leukopenia in urogenital cancer patients treated with chemotherapy].
    Oishi K, Takeuchi H, Yoshida O, Nakagawa K, Fukuyama T, Okamoto K, Kihara Y, Okuno H, Shirahase T, Tomoyoshi T.
    Hinyokika Kiyo; 1989 Mar; 35(3):527-36. PubMed ID: 2660519
    [Abstract] [Full Text] [Related]

  • 6. Stimulatory effect of romurtide on hematopoiesis in monkeys.
    Nakajima R, Yshida Y, Akahane K, Sekiguchi M, Osada Y.
    Arzneimittelforschung; 1991 Jan; 41(1):60-5. PubMed ID: 2049113
    [Abstract] [Full Text] [Related]

  • 7. Hematological response to the new synthetic muramyl dipeptide derivative muroctasin after chemotherapy in patients with malignant lymphoma. A randomized crossover trial.
    Hiraoka A, Masaoka T, Satoh T, Ota K, Oyama A, Horiuchi A, Hasegawa H, Nagai K, Kosaki M, Kanemaru A.
    Arzneimittelforschung; 1988 Oct; 38(10):1499-501. PubMed ID: 3058133
    [Abstract] [Full Text] [Related]

  • 8. [Activation of neutrophil function by MDP-Lys(L 18)].
    Hirota M, Senju R, Kadota J, Hiratani K, Komori K, Kanda T, Hara K, Hayashi K, Tsuji Y, Watanabe K.
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):219-24. PubMed ID: 2919891
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of platelet recovery in X-irradiated guinea pigs by romurtide, a synthetic muramyl dipeptide derivative.
    Namba K, Otani T, Osada Y.
    Blood; 1994 May 01; 83(9):2480-8. PubMed ID: 8167336
    [Abstract] [Full Text] [Related]

  • 10. [Use of filgrastim, granulocyte colony stimulating factor (G-CSF), in radiotherapy to reduce drop-outs because of radiogenic leukopenia].
    Gava A, Bertossi L, Ferrarese F, Coghetto F, Marazzato G, Andrulli AD, Zorat PL.
    Radiol Med; 1998 Mar 01; 95(3):232-6. PubMed ID: 9638171
    [Abstract] [Full Text] [Related]

  • 11. Romurtide, a synthetic muramyl dipeptide derivative, accelerates peripheral platelet recovery in nonhuman primate chemotherapy model.
    Namba K, Nitanai H, Otani T, Azuma I.
    Vaccine; 1996 Oct 01; 14(14):1322-6. PubMed ID: 9004440
    [Abstract] [Full Text] [Related]

  • 12. Restorative effect of muroctasin on leukopenia caused by anticancer chemotherapy in lung cancer. Comparative study by envelope method.
    Fukuoka M, Takada M, Takifuji N, Sakai N, Ryu S, Masuda N, Matsui K, Negoro S, Kusunoki Y, Tubura E.
    Arzneimittelforschung; 1989 Jan 01; 39(1):90-3. PubMed ID: 2719748
    [Abstract] [Full Text] [Related]

  • 13. Review: inducer of cytokines in vivo: overview of field and romurtide experience.
    Azuma I.
    Int J Immunopharmacol; 1992 Apr 01; 14(3):487-96. PubMed ID: 1618600
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment.
    Bahr GM, De La Tribonniere X, Darcissac E, Ajana F, Bocket L, Sissoko D, Yazdanpanah Y, Dewulf J, Amiel C, Mouton Y.
    J Antimicrob Chemother; 2003 Jun 01; 51(6):1377-88. PubMed ID: 12716777
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA, O'Brien S, Thomas DA, Pierce SA, Lam TP, Kantarjian HM.
    Cancer; 2002 Jan 15; 94(2):285-91. PubMed ID: 11900213
    [Abstract] [Full Text] [Related]

  • 19. Restorative effect of MDP-Lys (L18) on leukopenia of cancer patient treated with radiotherapy.
    Okawa T, Kikuchi Y, Watarai J, Dokiya T, Tanaka T, Saito Y, Hirokawa Y, Takegawa Y, Hata K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Apr 25; 48(4):514-22. PubMed ID: 3231516
    [No Abstract] [Full Text] [Related]

  • 20. Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study.
    Joseph CD, Praveenkumar V, Kuttan G, Kuttan R.
    J Exp Clin Cancer Res; 1999 Sep 25; 18(3):325-9. PubMed ID: 10606177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.